# Exploring the Link Between COVID-19 and Liver Abscess Formation: A Tertiary Care Center-Based Analysis of Pathophysiological Insights and Clinical Implications

**Authors:** Ramlakhan S Verma, Shailendra Pal Singh, Gaurav Mishra, Vikas K Patel, Vipin Gupta

PMC · DOI: 10.7759/cureus.94136 · 2025-10-08

## TL;DR

This study found that severe COVID-19, especially in patients with diabetes or liver cirrhosis, increases the risk of developing liver abscesses.

## Contribution

The study provides new clinical insights into the association between severe COVID-19 and liver abscess formation in high-risk patients.

## Key findings

- 60% of liver abscess patients had a history of COVID-19.
- Severe inflammatory markers were linked to both severe COVID-19 and liver abscess risk.
- Percutaneous drainage achieved an 80% recovery rate in treated patients.

## Abstract

Background

Liver abscess is a potential concern among liver health complications. With severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) capable of inducing inflammation and immune dysfunction, this study aimed to examine the association between COVID-19 infection and liver abscess risk.

Methods

This prospective study was conducted at Uttar Pradesh University of Medical Sciences (UPUMS), Saifai, Etawah, India. A sample of 150 patients with radiologically diagnosed liver abscesses was enrolled. Patient data, including COVID-19 history, clinical characteristics, and comorbidities, were collected, and laboratory parameters were analyzed, including inflammatory markers like C-reactive protein (CRP) and interleukin 6 (IL-6).

Results

The average age of participants was 48.3 years, with a male preponderance (73.3%). Among those with liver abscesses, 60% had a history of COVID-19, and of these, 43.3% required hospitalization, with 20% needing ICU care. High prevalence rates of diabetes (40%) and liver cirrhosis (23.3%) were noted. Percutaneous drainage was the most common treatment, achieving a recovery rate of 80%. Elevated inflammatory markers were significantly associated with COVID-19 severity and liver abscess risk.

Conclusion

The study highlighted that severe COVID-19, especially in patients with diabetes or liver cirrhosis, increases the risk of liver abscess. Routine monitoring for liver health in these patients is recommended.

## Linked entities

- **Proteins:** IL6 (interleukin 6)
- **Diseases:** COVID-19 (MONDO:0100096), diabetes (MONDO:0005015)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}
- **Diseases:** diabetes (MESH:D003920), Liver Abscess (MESH:D008100), inflammation (MESH:D007249), immune dysfunction (MESH:D007154), liver cirrhosis (MESH:D008103), COVID-19 (MESH:D000086382)
- **Species:** Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC12594266